Related articles
Amyloid removal may curb Alzheimer's progression for years
In an Alzheimer’s disease patient’s brain, regions cleared of amyloid had little tau; nearby areas with persistent amyloid had greater signs of damage.
Novel medicine for rare disease prompts $10M gift for trials
The Clayco Foundation award will go toward safety trials of a new small molecule drug aimed at treating RVCL, a rare, fatal disease with no cure.
Subscribe
Subscribe to Penn Medicine newsletters and publications for the latest developments.